1. One‐year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal‐time insulin: the EDITION 1 12‐month randomized trial, including 6‐month extension. Issue 9 (11th May 2015) Authors: Riddle, M. C.; Yki‐Järvinen, H.; Bolli, G. B.; Ziemen, M.; Muehlen‐Bartmer, I.; Cissokho, S.; Home, P. D. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 9(2015:Sep.) Page Start: 835 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗